ConductScience.org, home

Gene · 3549

NIH grants2,031

NIH grants whose papers are about the gene, through NIH's grant-paper links.

181 to 200 of 2,031

Download this page as JSON
GrantTitleIHH papersNewest fiscal year
R01CA258684Regulation of GLI1, a synthetic lethal target of SMARCA4-deficiency, in lung adenocarcinoma12025
R01DA053372Effect of methadone on the developmental properties of human brain organoids12025
R01DC004336Engineering the Vocal Fold Mucosa12025
R01DE024772Microribbon scaffold-mediated Immunomodulation for Cranial Bone Repair12025
R01DE029465Discoidin Domain Receptor 2, β1 Integrins and ECM Control of Bone Formation12025
R01DE030491Mineralized collagen composite to accelerate craniofacial bone regeneration12025
R01DE030536Regulation of Alveolar Bone Marrow MSC Senescence in Skeletal Aging and Periodontitis12025
R01DE030565Dissecting single cell dynamics that coordinate neural crest migration and diversification12025
R01DE030596Coronal Suture Development in Health and Disease12025
R01DK044319Characterization of Mucosal Lymphocytes12025
R01DK051362Regulation of Mucosal Lymphocytes12025
R01DK062370Identifying Genes for Type 2 Diabetes: FUSION12025
R01DK072381Kidney Injury Molecule-1 in Epithelial Repair12025
R01DK088199Endoplasmic reticulum stress and intestinal inflammation12025
R01DK093757Genetic epidemiology of rare and regulatory variants for metabolic traits12025
R01DK094989REGULATION OF ATROPHY-INDUCED PROGENITOR CELLS IN THE GASTRIC CORPUS12025
R01DK095201Control of iron absorption by intestinal HIF2 in iron and hematological disorders12025
R01DK099205Epigenetics of human Hepatic Stellate Cells (HSCs) in NASH12025
R01DK101737The Role of Portal Fibroblasts in Cholestatic Liver Fibrosis12025
R01DK105129MECHANISMS OF CHIEF CELL DEDIFFERENTIATION12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3549/grants?page=10